Safety and Efficacy Study of High Dose Melphalan to Treat Multiple Myeloma
Clinical trial NCT01572688 · UNKNOWN
Trial details
- NCT number
- NCT01572688
- Sponsor
- Shandong Lanjin Pharmaceuticals Co.,Ltd
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2011-11-01
- Primary completion
- 2014-06-01
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.